NASDAQ · MEDS
Healthcare · Medical - Pharmaceuticals
$3.07
Down-$0.20 (-6.51%)
Updated Oct 7, 2026, 7:48 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · MEDS
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
MEDS closed at $3.07 after 21 trading sessions, up 252.43% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $3.20 | $3.36 | $3.04 | $3.07 | 640.11K |
| Oct 5, 2026 | $3.55 | $3.67 | $3.35 | $3.35 | 659.05K |
| Oct 2, 2026 | $3.86 | $3.94 | $3.56 | $3.68 | 1.17M |
| Oct 1, 2026 | $3.90 | $4.35 | $3.63 | $4.06 | 34.9M |
| Sep 30, 2026 | $3.48 | $3.48 | $3.17 | $3.17 | 556.55K |
| Sep 29, 2026 | $3.90 | $3.96 | $3.60 | $3.67 | 1.48M |
| Sep 28, 2026 | $3.97 | $4.65 | $3.44 | $3.81 | 33.44M |
| Sep 25, 2026 | $3.43 | $3.445 | $3.01 | $3.11 | 418.39K |
| Sep 24, 2026 | $3.65 | $3.7713 | $3.44 | $3.50 | 317.59K |
| Sep 23, 2026 | $4.01 | $4.0872 | $3.80 | $3.83 | 595.57K |
| Sep 22, 2026 | $4.10 | $5.38 | $3.91 | $4.275 | 2.42M |
| Sep 21, 2026 | $4.17 | $4.55 | $3.75 | $4.18 | 2.08M |
| Sep 18, 2026 | $5.97 | $6.29 | $3.45 | $3.76 | 15.85M |
| Sep 17, 2026 | $6.73 | $6.75 | $4.03 | $4.64 | 7.17M |
| Sep 16, 2026 | $4.035 | $12.31 | $4.0001 | $6.07 | 188.78M |
| Sep 15, 2026 | $0.8949 | $3.85 | $0.865 | $1.62 | 65.06M |
| Sep 14, 2026 | $0.88 | $0.8998 | $0.86 | $0.8653 | 56.67K |
| Sep 11, 2026 | $0.9072 | $0.935 | $0.8614 | $0.9001 | 87.97K |
| Sep 10, 2026 | $0.8799 | $0.903 | $0.8501 | $0.892 | 80K |
| Sep 9, 2026 | $0.871 | $0.95 | $0.851 | $0.851 | 148.64K |
| Sep 8, 2026 | $0.9153 | $0.9188 | $0.8526 | $0.8711 | 136.68K |
The latest Smart Investors Daily articles mentioning MEDS.
Company
Market Activity
Research & News
MEDS research
Company profile and research snapshot.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 16, 2023 | EF Hutton | Buy | — |
| Mar 28, 2023 | Maxim Group | Buy | — |
| Dec 9, 2021 | EF Hutton | Buy | — |
| Dec 3, 2020 | National Securities | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 1, 2026
Corexa Pharmacy’s preliminary September revenue increased more than 66% from July, supported by retail customer growth and the launch of Tollo Health products. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) said Corexa Pharmacy generated preliminary, unaudited September 2026 revenue of more than $1 million.
Yahoo · Oct 1, 2026
September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launchesTAMPA, FL / ACCESS Newswire / October 1, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today provided a revenue update on
Yahoo · Sep 28, 2026
Axe Compute stock has rallied over 650% in the past six months as investors increasingly value it as an AI infrastructure stock. The challenge is now delivering on that promise.
Yahoo · Sep 28, 2026
DataMeds AI (NASDAQ:MEDS) and Tollo Health launched the Health Lives Here mobile application, combining GLP-1 telehealth, pharmacy services, nutritional products and health tracking as part of a planned broader healthcare network. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) and Tollo Health have launched Health Lives Here, initially targeting patients using GLP-1 receptor agonist medications.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MEDS.
